Pages that link to "Q33545615"

The following pages link to National guidelines needed to manage rhinitis and prevent complications (Q33545615):

Displaying 25 items.

• Chronic sinusitis pathophysiology: the role of allergy (Q27692520) (← links)
• The impact of rhinosinusitis on asthma (Q28165588) (← links)
• Chronic rhinosinusitis phenotypes (Q30275962) (← links)
• Chronic rhinosinusitis and antibiotics: the good, the bad, and the ugly (Q30416254) (← links)
• Fungi in chronic hyperplastic eosinophilic sinusitis: reasonable doubt (Q30440792) (← links)
• Sinusitis and its relationship to asthma. Can treating one airway disease ameliorate another? (Q34066981) (← links)
• Antihistamines in late-phase clinical development for allergic disease (Q34519151) (← links)
• Prevalence and differential diagnosis of chronic rhinitis (Q34561617) (← links)
• Upper airway disorders and asthma: a syndrome of airway inflammation (Q34625509) (← links)
• Asthma, allergy, and upper airway disease (Q35649020) (← links)
• Allergic rhinitis in children : diagnosis and management strategies (Q35875669) (← links)
• Impact of Functional Endoscopic Sinus Surgery on the Pulmonary Function of Patients with Chronic Rhinosinusitis: A Prospective Study (Q36064083) (← links)
• Comparison of asthma-related functional consequences and health care utilization among children with and without upper respiratory infection-triggered wheezing (Q36627821) (← links)
• Desloratadine and pseudoephedrine combination therapy as a comprehensive treatment for allergic rhinitis and nasal congestion (Q37497398) (← links)
• A milestone in house dust-mite-allergen immunotherapy: the new sublingual tablet S-524101 (actair). (Q38262772) (← links)
• Mometasone furoate monohydrate nasal spray for the treatment of nasal congestion in allergic rhinitis (Q43061697) (← links)
• Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis (Q43795638) (← links)
• Effect of betamethasone-loratadine combination therapy on severe exacerbations of allergic rhinitis : a randomised, controlled trial (Q46214284) (← links)
• Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis (Q46413447) (← links)
• Use of intranasal corticosteroids in the management of congestion and sleep disturbance in pediatric patients with allergic rhinitis (Q48446467) (← links)
• Relationship between chronic nasal and respiratory symptoms in patients with COPD. (Q51658373) (← links)
• The link between allergic rhinitis and allergic asthma: a prospective population-based study. The Copenhagen Allergy Study (Q51702086) (← links)
• The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years (Q73928095) (← links)
• Allergic rhinitis: nothing to sniffle at (Q77415690) (← links)
• Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen–induced rhinoconjunctivitis (Q84622445) (← links)